Information portal on various topics of management of public resources of the Portuguese State

Project sheet

Name

Paralab Chair in 3D printing

Total project amount

246,79 thousand €

Amount paid

0 €

Non-refundable funding

246,79 thousand €

Loan funding

0 €

Start date

01.02.2025

Expected end date

31.03.2026

Dimension

Resilience

Component

Qualifications and Skills

Investment

Science Plus Training

Operation code

02/C06-i06/2024.P2023.15056.TENURE.065

Summary

CBQF Chair in 3D printing will be primarily responsible for leading and executing innovative research projects at the intersection of biomedical engineering and 3D printing technologies. The candidate will collaborate closely with both academic and industrial teams, leveraging the capabilities of the CBQF and Paralab to develop new medical devices and 3D printing applications.Key tasks include:Lead projects aimed at the design and development of new biomedical devices using 3D printing technology.Explore and develop new bio-compatible materials (bioinks) suitable for 3D printing applications.Utilize 3D printing for rapid prototyping of device designs.Work closely with researchers, clinicians, and engineers within the CBQF and Paralab, as well as with external partners, to integrate cutting-edge 3D printing technologies into biomedical research and development projects.Act as a liaison between the technical team and non-technical stakeholders, translating complex engineering concepts into understandable terms and demonstrating the potential impact of 3D printed biomedical solutions.Manage the lifecycle of 3D printing projects from conception through to completion, ensuring they are delivered on time, within scope, and budget.Keep up on the latest developments in 3D printing technology and biomedical engineering research to identify opportunities for innovation and improvement.Engage in continuous professional development to enhance technical skills in 3D printing and broaden knowledge in biomedical engineering, attending workshops, conferences, and courses relevant to the field.Facilitating technology transfer from research to production stages.The ideal candidate should possess a Ph.D. in Biomedical Engineering and  Regenerative Medicine or a closely related field, with a strong emphasis on 3D printing technologies. Essential skills and qualifications include:Proven expertise in 3D printing techniques and materials, particularly as applied to biomedical engineering.Experience in the design, development, and testing of novel biomaterials (bioinks).Knowledge of Innovation and Technology Integration (Technology transfer).Comprehensive Business Knowledge and strategic thinking.Strong publication record in peer-reviewed journals.Excellent problem-solving abilities and a collaborative mindset.Ability to work effectively across interdisciplinary teams and projects.The proposed hiring is totally aligned with CBQF-UCP and Paralab goals and under the scope of Biomaterials and Biomedical Technology laboratory at CBQF-UCP, envisioning the development of multidisciplinary research strategies in biomedical research.Recently, Paralab, through its Paralab Bio division, entered into a strategic distribution agreement with CELLINK, a global pioneer in 3D bioprinting (https://paralab.pt/noticias/paralab-faz-parceria-com-a-cellink-para-promover-a-bioimpressao-3d-em-portugal-e-espanha/ ).The hiring of a 3D printing manager is crucial to bridge the gap between innovative biomedical research and practical medical solutions. This position will enable CBQF-UCP and Paralab to remain at the forefront of biomedical engineering research, fostering the development of groundbreaking 3D printing research. Additionally, this role will facilitate the translation of academic research into commercially viable products, enhancing the impact of the scientific discoveries on healthcare. This synergy between the CBQF-UCP and Paralab represents a strategic initiative to leverage academic research for industrial applications. The new hire will play a key role in this process, aiming to establish a robust pipeline of innovative medical devices and biomaterials (bioinks), setting new standards in the field of 3D printing.

Beneficiaries

Within the scope of the Recovery and Resilience Plan, two types of beneficiaries are responsible for carrying out the projects and using the funding provided. Due to their similar role, the reference to these two types of beneficiaries has been simplified and unified under the term "Beneficiary".
The two types are::
  • Direct Beneficiaries are those whose funding and projects to implement are part of the Recovery and Resilience Plan that has been negotiated and approved by the European Union;
  • Final Beneficiaries are those whose funding and projects to implement are approved following a selection process through Calls for Applications.

Call for applications

As part of the Call for Applications, submissions are requested to select the projects and final beneficiaries to whom funding will be awarded. Specific selection criteria are defined for each call, which must be reflected in the applications submitted and assessed.

The project is appraised on the basis of its compliance with the selection criteria laid down in the calls for applications, and a final score may be awarded, where applicable.

Final evaluation score

9,0
Important note

The components for calculating the assessment score can be found in the selection criteria document mentioned below.

Selection criteria

The funding selection criteria to which this project and its final beneficiary were subject and its score can be found in detail on the Recuperar Portugal platform.

Beneficiaries

Intermediate beneficiaries

Beneficiaries

Procurement

Beneficiaries representing public entities implement their project by signing one or more contracts with suppliers for goods or services through public procurement procedures.

To ensure and provide the utmost transparency in all these contracts, a list of the contracts that were signed under this project is available here, along with the information available on the Base.Gov platform. Please note that, according to the legislation in force at the time the contract was signed, some exceptions do not require the publication of the contracts signed on this platform, and, therefore, no information is available in such cases.

Geographic distribution

246,79 thousand €

Total amount of the project

Where was the money spent

By county

1 county financed .

  • Lisboa 246,79 thousand € ,
Source EMRP
10.02.2026
All themes
Transparency without leading